Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Striatin-3 (STRN3) is a calmodulin-binding scaffolding protein that serves as a core regulator within the STRIPAK complex, a multi-protein assembly that critically controls protein (de)phosphorylation and modulates several signaling pathways, including Hippo, MAPK, and cytoskeletal organization[1][3][7]. As a regulatory subunit of protein phosphatase 2A (PP2A), STRN3 helps coordinate kinase and phosphatase activities, influencing cell growth, invasion, and transcriptional regulation[3][1]. STRN3 plays important roles in balancing cell proliferation, migration, and tissue invasion, particularly through cooperative interactions with kinases such as MAP4K4 and via negative regulation of Hippo signaling[1][3][4]. Disruption of STRN3 can impair tumor cell growth and invasion, highlighting its relevance in cancer biology, including reported involvement in hepatocellular carcinoma and medulloblastoma[1][4]. STRN3 is encoded by the STRN3 gene and is mainly localized in the nucleoplasm, Golgi apparatus, and plasma membrane[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Striatin-3 (STRN3).